Data News > Walgreens Boots Alliance (WBA) Beats Estimates with Strong Q1 Earnings Report
- Walgreens Boots Alliance (WBA) reported quarterly earnings of $0.51 per share, surpassing the Zacks Consensus Estimate of $0.37 per share.
- First-quarter sales totaled $39.46 billion, up 7.5% year over year, beating expectations.
- The pharmacy retailer's stock rose as sales grew, and adjusted earnings exceeded analyst estimates.
- Analysts are optimistic about Walgreens' stock, predicting a rebound in the near future.
- Despite a $265 million loss, the company sees progress on its turnaround efforts and maintains its annual profit forecast.
Walgreens Boots Alliance (WBA) exceeded expectations in its first-quarter earnings report, with a quarterly earnings per share of $0.51, beating the Zacks Consensus Estimate of $0.37. This marks a decrease compared to earnings of $0.66 per share in the same period last year. The pharmacy retailer's stock surged following the positive earnings report, as investors reacted positively to the news of better-than-expected performance.
The company reported first-quarter sales of $39.46 billion, reflecting a 7.5% increase year over year (+6.9% on a constant currency basis). This figure surpassed the consensus estimate of $37.28 billion, showcasing sales growth across all segments of Walgreens Boots Alliance. The strong sales performance contributed to the overall positive outlook for the company's financial health moving forward.
Walgreens Boots Alliance's stock saw a significant increase following the release of the first-quarter results, as shares rose on Friday morning. The better-than-expected revenue and adjusted profits reported by the company exceeded analyst predictions, leading to increased investor confidence in Walgreens' future prospects. The positive momentum in sales growth contributed to the upbeat sentiment surrounding the pharmacy retailer.
Analysts are optimistic about the future performance of Walgreens Boots Alliance NASDAQ: WBA stock, as charts and sell-side activity suggest a potential rebound in the near future. Despite facing challenges and headwinds, the company's stock is currently trading at only 6x earnings, indicating a high-yielding deep-value opportunity for investors. With the potential for a turnaround on the horizon, analysts are bullish on the outlook for Walgreens' stock moving forward.
Despite reporting a $265 million loss in the first quarter, Walgreens Boots Alliance sees progress on its turnaround efforts. CEO Tim Wentworth emphasized the company's commitment to stabilizing the retail pharmacy business by optimizing its footprint, controlling operating costs, and improving cash flow. The continued focus on addressing reimbursement models and slashing costs has positioned Walgreens for future success, despite the challenges faced in the past year.
Walgreens Boots Alliance's strong performance in the first quarter of fiscal 2025 showcases the company's dedication to its turnaround efforts and strategic priorities. CEO Tim Wentworth highlighted the disciplined execution against the 2025 goals, emphasizing the company's focus on stabilizing the retail pharmacy business and improving overall financial performance. With continued progress on its turnaround initiatives, Walgreens is poised for a successful future, despite the challenges encountered in the past year.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Walgreens Boots Alliance (WBA) Beats Estimates with Strong Q1 Earnings Report
By KlickAnalytics Data Insights | January 10, 2025 10:00AM ET
Key Points
- Walgreens Boots Alliance (WBA) reported quarterly earnings of $0.51 per share, surpassing the Zacks Consensus Estimate of $0.37 per share.
- First-quarter sales totaled $39.46 billion, up 7.5% year over year, beating expectations.
- The pharmacy retailer's stock rose as sales grew, and adjusted earnings exceeded analyst estimates.
- Analysts are optimistic about Walgreens' stock, predicting a rebound in the near future.
- Despite a $265 million loss, the company sees progress on its turnaround efforts and maintains its annual profit forecast.
Walgreens Boots Alliance (WBA) exceeded expectations in its first-quarter earnings report, with a quarterly earnings per share of $0.51, beating the Zacks Consensus Estimate of $0.37. This marks a decrease compared to earnings of $0.66 per share in the same period last year. The pharmacy retailer's stock surged following the positive earnings report, as investors reacted positively to the news of better-than-expected performance.
The company reported first-quarter sales of $39.46 billion, reflecting a 7.5% increase year over year (+6.9% on a constant currency basis). This figure surpassed the consensus estimate of $37.28 billion, showcasing sales growth across all segments of Walgreens Boots Alliance. The strong sales performance contributed to the overall positive outlook for the company's financial health moving forward.
Walgreens Boots Alliance's stock saw a significant increase following the release of the first-quarter results, as shares rose on Friday morning. The better-than-expected revenue and adjusted profits reported by the company exceeded analyst predictions, leading to increased investor confidence in Walgreens' future prospects. The positive momentum in sales growth contributed to the upbeat sentiment surrounding the pharmacy retailer.
Analysts are optimistic about the future performance of Walgreens Boots Alliance NASDAQ: WBA stock, as charts and sell-side activity suggest a potential rebound in the near future. Despite facing challenges and headwinds, the company's stock is currently trading at only 6x earnings, indicating a high-yielding deep-value opportunity for investors. With the potential for a turnaround on the horizon, analysts are bullish on the outlook for Walgreens' stock moving forward.
Despite reporting a $265 million loss in the first quarter, Walgreens Boots Alliance sees progress on its turnaround efforts. CEO Tim Wentworth emphasized the company's commitment to stabilizing the retail pharmacy business by optimizing its footprint, controlling operating costs, and improving cash flow. The continued focus on addressing reimbursement models and slashing costs has positioned Walgreens for future success, despite the challenges faced in the past year.
Walgreens Boots Alliance's strong performance in the first quarter of fiscal 2025 showcases the company's dedication to its turnaround efforts and strategic priorities. CEO Tim Wentworth highlighted the disciplined execution against the 2025 goals, emphasizing the company's focus on stabilizing the retail pharmacy business and improving overall financial performance. With continued progress on its turnaround initiatives, Walgreens is poised for a successful future, despite the challenges encountered in the past year.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.